Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Late Endocrine and Metabolic Consequences of Treatment of Primary Brain Tumors in Childhood

NCT07457255 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.

NCT NCT07457255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07457255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Late Endocrine and Metabolic Consequences of Treatment of Primary Brain Tumors in Childhood
Lead sponsor
Institute of Oncology Ljubljana
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2023
Completion date
December 31, 2025
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood brain tumors, endocrine disorders